AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Revenue

AmCad BioMed had revenue of 6.39M TWD in the quarter ending March 31, 2026, a decrease of -5.80%. This brings the company's revenue in the last twelve months to 30.04M, down -42.01% year-over-year. In the year 2025, AmCad BioMed had annual revenue of 30.44M, down -42.69%.

• Revenue (ttm): 30.04M
• Revenue Growth: -42.01%
• P/S Ratio: 23.50
• Revenue / Employee: 883.65K
• Employees: 34
• Market Cap: 706.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.44M	-22.67M	-42.69%
Dec 31, 2024	53.11M	-12.15M	-18.62%
Dec 31, 2023	65.26M	3.63M	5.88%
Dec 31, 2022	61.63M	-24.16M	-28.16%
Dec 31, 2021	85.79M	21.85M	34.17%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error